Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Molecular Cancer Therapeutics|January 11, 2024
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer ModelsHirokazu Suzuki, Shotaro Nagase, Chiemi Saito, et al.Scientific Reports|October 21, 2025
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyesFumiko Murao, Ryoji Yanai, Sentaro Kusuhara, et al.The Review of Scientific Instruments|May 2, 2016
Development of Compton X-ray spectrometer for high energy resolution single-shot high-flux hard X-ray spectroscopySadaoki Kojima, Takahito Ikenouchi, Yasunobu Arikawa, et al.Bioorganic & Medicinal Chemistry Letters|September 8, 2016
Wide application of a novel topoisomerase I inhibitor-based drug conjugation technologyYusuke Ogitani, Yuki Abe, Takuma Iguchi, et al.Journal of Natural Medicines|October 21, 2017
Four new diterpenoid alkaloids from Aconitum japonicum subsp. subcuneatumHiroshi Yamashita, Keiko Takeda, Machiko Haraguchi, et al.Nature Communications|July 12, 2024
Single-shot laser-driven neutron resonance spectroscopy for temperature profilingZechen Lan, Yasunobu Arikawa, Seyed Reza Mirfayzi, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 25, 2023
Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbationYichi Yang, Hirokazu Kimura, Isao Yokota, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1Yusuke Ogitani, Tetsuo Aida, Katsunobu Hagihara, et al.Cancer Science|December 15, 2018
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modesShiho Ueda, Hidemi Hayashi, Takako Miyamoto, et al.Molecular Cancer Therapeutics|July 10, 2025
DS-3939a: A TA-MUC1-directed Antibody-Drug Conjugate with Broad Anti-Tumor ActivityKohei Takano, Mayuko Yukiura, Kazuki Takahashi, et al.Pageof 14